1.47
price down icon5.16%   -0.08
pre-market  Vorhandelsmarkt:  1.44   -0.03   -2.04%
loading

Finanzdaten der Soligenix Inc-Aktie (SNGX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 0.00234
Operating Expenses
8.68%
2.7639
3.0265 3.7125 1.8652 1.7447
Operating Income/Loss
8.68%
-2.7639
-3.0265 -3.7125 -1.8652 -1.7447
Nonoperating Income/Loss
17.73%
0.0619
0.0752 0.316 0.1459 0.1002
Income/Loss From Continuing Operations Before Tax
16.52%
-2.702
-3.2368 -3.3965 -1.7194 -1.6445
Income/Loss From Continuing Operations After Tax
8.45%
-2.702
-2.9513 -2.9874 -1.7194 -1.6445
Net Income/Loss
16.52%
-2.702
-3.2368 -2.9874 -1.7194 -1.6445
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7.51%
3.2787
3.0496 0.2838 2.2039 1.259
Diluted Average Shares
7.51%
3.2787
3.0496 0.2838 2.2039 1.259
Basic Earnings Per Share
15.46%
-0.82
-0.97 -1.14 -0.78 -1.31
Diluted Earnings Per Share
15.46%
-0.82
-0.97 -1.14 -0.78 -1.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):